Literature DB >> 2467570

Response to exogenous cholecystokinin of six human gastrointestinal cancers xenografted in nude mice.

C Hudd1, M C LaRegina, J E Devine, D C Palmer, D R Herbold, M C Beinfeld, F B Gelder, F E Johnson.   

Abstract

Gastrointestinal hormones regulate growth of cancers as well as normal tissues. We investigated whether long-term cholecystokinin (CCK) administration might affect growth or metabolism of human tumors xenografted in nude mice. In each experiment, approximately 20 nude mice bearing subcutaneous xenografts of the particular cancer line being studied were used. Half received CCK and half received saline solution intraperitoneally twice daily for 14 days. Tumor volume and body weight were measured every 3 days. If the tumors produced marker substances, these were measured in nude mouse serum and also in the xenografts. Tumor growth was significantly retarded by CCK in two of the six cancers studied. In each case, DNA, RNA, and protein reflected tumor volumes. In one of these tumors (SLU 077), serum carcinoembryonic antigen (CEA) levels paralleled the tumor volumes. In another tumor (SLU 132), serum CEA levels and tumor immunolabeling for CEA and pancreatic oncofetal antigen increased in response to CCK administration, whereas tumor volumes did not. These findings suggest that exogenous highdose CCK altered the growth and metabolism in two of six human cancers studied.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2467570     DOI: 10.1016/0002-9610(89)90582-5

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  10 in total

1.  Cholecystokinin stimulates growth of human pancreatic adenocarcinoma SW-1990.

Authors:  J P Smith; T E Solomon; S Bagheri; S Kramer
Journal:  Dig Dis Sci       Date:  1990-11       Impact factor: 3.199

Review 2.  On the role of cholecystokinin in pancreatic cancer.

Authors:  M K Herrington; T E Adrian
Journal:  Int J Pancreatol       Date:  1995-04

3.  Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma.

Authors:  D S Weinberg; B Ruggeri; M T Barber; S Biswas; S Miknyocki; S A Waldman
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

4.  Presence of CCK-A, B receptors and effect of gastrin and cholecystokinin on growth of pancreatobiliary cancer cell lines.

Authors:  Jin-Young Jang; Sun-Whe Kim; Ja-Lok Ku; Yong-Hyun Park; Jae-Gahb Park
Journal:  World J Gastroenterol       Date:  2005-02-14       Impact factor: 5.742

5.  Effects of cholecystokinin octapeptide on a pancreatic acinar carcinoma in the rat.

Authors:  A Hajri; C Damgé
Journal:  Pharm Res       Date:  1998-11       Impact factor: 4.200

Review 6.  Gastrointestinal hormones as potential adjuvant treatment of exocrine pancreatic adenocarcinoma.

Authors:  W E Fisher; P Muscarella; L G Boros; W J Schirmer
Journal:  Int J Pancreatol       Date:  1998-12

Review 7.  Hormones and pancreatic cancer.

Authors:  D S Longnecker
Journal:  Int J Pancreatol       Date:  1991

8.  Cholecystokinin-A receptor messenger RNA expression in human pancreatic cancer.

Authors:  R Moonka; W Zhou; R H Bell
Journal:  J Gastrointest Surg       Date:  1999 Mar-Apr       Impact factor: 3.267

9.  A randomised trial of octreotide vs best supportive care only in advanced gastrointestinal cancer patients refractory to chemotherapy.

Authors:  S Cascinu; E Del Ferro; G Catalano
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640

Review 10.  In Vivo Models for Cholangiocarcinoma-What Can We Learn for Human Disease?

Authors:  Raphael Mohr; Burcin Özdirik; Jana Knorr; Alexander Wree; Münevver Demir; Frank Tacke; Christoph Roderburg
Journal:  Int J Mol Sci       Date:  2020-07-15       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.